Omada Health Expands Weight Management Program with New Medication Offerings

November 7, 2025 - 03:16

In a significant development for the health tech industry, Omada Health has announced the expansion of its weight management program to include the prescribing of GLP-1 medications and other obesity treatments. This move comes as the company celebrates a remarkable growth in its membership, which has now surpassed 100,000 individuals.

The introduction of these medications aims to provide a more comprehensive approach to weight management, addressing the needs of those struggling with obesity. GLP-1 receptor agonists, known for their effectiveness in promoting weight loss and improving metabolic health, will now be part of the resources available to members.

Omada Health's commitment to enhancing its offerings reflects a growing recognition of the importance of personalized care in combating obesity. As the demand for effective weight management solutions continues to rise, the company's new initiative positions it as a leader in the health tech space, promising to support individuals on their journey to better health and wellness.